Name
Osaühing Ars Medica
Registry code
10811001
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.10.2001 (23)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86221 - Provision of specialised medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Katrin Krüünvald 25.11.1963 (60) | 50% - 1 278.00 EUR | Board member | Direct ownership | Founder |
Margus Krüünvald 08.08.1963 (61) | 50% - 1 278.00 EUR | Board member | Direct ownership | Founder |
2019 07.01.2021 | 2020 01.02.2022 | 2021 20.12.2022 | 2022 31.10.2023 | |
---|---|---|---|---|
Total Revenue | 916 922 € | 775 722 € | 781 871 € | 791 605 € |
Net profit (loss) for the period | 424 033 € | 425 268 € | 425 635 € | 306 928 € |
Profit Margin | 46% | 55% | 54% | 39% |
Current Assets | 4 005 367 € | 4 142 711 € | 4 358 613 € | 4 278 075 € |
Fixed Assets | 13 070 € | 249 839 € | 60 322 € | 381 921 € |
Total Assets | 4 018 437 € | 4 392 550 € | 4 418 935 € | 4 659 996 € |
Current Liabilities | 705 377 € | 665 266 € | 266 016 € | 400 150 € |
Non Current Liabilities | - | - | - | - |
Total Liabilities | - | - | - | - |
Share Capital | - | - | - | - |
Equity | 3 313 060 € | 3 727 284 € | 4 152 919 € | 4 259 846 € |
Employees | 5 | 5 | 5 | 5 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 26 830.28 € | 9 602.17 € | 2 |
2023 Q4 | - | 27 867.99 € | 9 904.84 € | 2 |
2023 Q3 | - | 12 345.99 € | 11 133.11 € | 2 |
2023 Q2 | - | 16 833.54 € | 16 255.55 € | 3 |
2023 Q1 | - | 39 005.29 € | 23 791.84 € | 15 |
2022 Q4 | - | 12 952.56 € | 13 614.64 € | 15 |
2022 Q3 | - | 16 491.92 € | 17 406.14 € | 15 |
2022 Q2 | - | 18 103.04 € | 19 138.25 € | 15 |
2022 Q1 | - | 41 318.76 € | 17 225.91 € | 15 |
2021 Q4 | - | 17 326.68 € | 16 930.25 € | 14 |
2021 Q3 | - | 18 418.28 € | 16 681.74 € | 14 |
2021 Q2 | - | 75 383.7 € | 22 802.08 € | 13 |
2021 Q1 | - | 15 118.04 € | 15 911.05 € | 16 |
2020 Q4 | - | 13 920.07 € | 14 689.84 € | 16 |
2020 Q3 | - | 12 849.71 € | 13 528.12 € | 16 |
2020 Q2 | - | 11 498 € | 12 185.35 € | 16 |
2020 Q1 | - | 25 532.74 € | 16 314.77 € | 15 |